Exercise-Based Pulmonary Rehabilitation for Interstitial Lung Diseases: A Review of Components, Prescription, Efficacy, and Safety.
Renata G Mendes, Viviane Castello-Simões, Renata Trimer and 6 others
PMID 36188788WHAT IT FOUND
Exercise-based pulmonary rehabilitation improves walking distance, symptoms, and quality of life in interstitial lung disease, but benefits often fade within six months.
Most trials used 8 to 12 weeks of combined aerobic and strength training, with safety data rarely reported.
Key findings
01Pulmonary rehabilitation programs typically last 8 to 12 weeks and produce significant improvements in functional capacity, quality of life, and breathlessness for patients with interstitial lung disease.
02While exercise tolerance and health status improve during rehabilitation, these benefits are not always sustained, with one study showing gains were not maintained six months after the intervention ended.
03The safety of exercise-based rehabilitation in this population is poorly studied, with most published trials failing to report adverse events or exacerbations during the program.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This is a narrative review, not a systematic review or meta-analysis, so the selection of studies may be biased. Safety data is severely lacking; most trials did not report adverse events or exacerbations. Long-term sustainability of benefits is inconsistent across studies, with some showing decline within six months. The review includes heterogeneous ILD populations, making it difficult to apply findings to specific subgroups without caution. Many studies did not measure adherence or physical activity levels after the intervention.
Declared interests
The authors declare no commercial or financial relationships that could be construed as a potential conflict of interest. Funding was provided by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) and Capes.
The easy way to misread this
Do not assume that exercise-based pulmonary rehabilitation is safe without monitoring. The review highlights that safety data is poorly studied and most trials did not report adverse events, despite the known risk of exertional hypoxemia and arrhythmias in this population.